Our Story
Faraday’s innovative approach to medicine stems from our beginnings
We are a clinical-stage biopharmaceutical company founded by Dr. Mark Roth of the Fred Hutchinson Cancer Center in Seattle and backed by an investor group led by ARCH Venture Partners and Polaris Partners.